Autologous Cell Therapy Market: By Source (Bone Marrow, Epidermis, and Others), By Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, Autoimmune Diseases, and Others), By End User (Hospitals, Ambulatory Centers, and Research Centers), and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Autologous Cell Therapy Market size was valued at USD 5.2 billion in 2022 and is poised to grow at a CAGR of 19.2% from 2023-2029. Owing to the increase in the prevalence of various incurable diseases and it is an effective and safer technology when compared to that of the existing transplantation technologies in the market. Moreover, benefits such as reduction of risks which are associated with bio-incompatibility, disease transmission and immunological reactions drives the growth of the market. The therapy involves treating a patient's own cells or tissues outside the body before reintroducing them into the donor. Currently, aesthetic and cosmetic dermatology, modern medicine, and orthopaedics all employ this kind of therapy. A number of autologous therapies exist with the goals of promoting wound healing, reducing chronic inflammation, and promoting wound closure. Autologous cell treatment draws on a variety of scientific disciplines and technologies, from virology to cellular and molecular biology. The Autologous blood vessel and artery grafts have also been used for a very long time in heart disease.

Global Autologous Cell Therapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

19.2%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Autologous Cell Therapy Market Dynamics

Sedentary lifestyle and poor dietary choices has fuelled the growth of the malignancy across the world. As per American Cancer Society, a million people are suffering from cancer in United States alone. Moreover, rising funds form the government and private organizations support in cell therapy clinical trials and proven effectiveness of products coupled declining prices of stem cell therapies drives the growth of the market.

Global Autologous Cell Therapy Market Segmentation

By Source
  • Bone Marrow
  • Epidermis
  • Others
By Application
  • Cancer
  • Neurodegenerative Diseases
  • Wound Healing
  • orthopedic
  • CVD
  • Autoimmune
  • Others
By End User
  • Hospitals
  • Ambulatory Centers
  • Research Centers

Frequently Asked Questions

2023 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Autologous Cell Therapy Market Introduction
2.1. Global Autologous Cell Therapy Market Taxonomy
2.2. Global Autologous Cell Therapy Market Definitions
2.2.1. Source
2.2.2. Application
2.2.3. End User
2.2.4. Region
3. Global Autologous Cell Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Autologous Cell Therapy Market Dynamic Factors - Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Autologous Cell Therapy Market, By Source, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Bone Marrow
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Epidermis
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Mesenchymal Stem Cells
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Hematopoietic Stem Cells
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Chondrocytes
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Autologous Cell Therapy Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Cancer
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Neurodegenerative Diseases
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Wound Healing
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Orthopedic
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Diseases
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Autoimmune Diseases
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Autologous Cell Therapy Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Hospitals and Clinics
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Academic and Research Institutes
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Autologous Cell Therapy Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, and Country, 2023 - 2029
9. North America Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Bone Marrow
9.1.2. Epidermis
9.1.3. Mesenchymal Stem Cells
9.1.4. Hematopoietic Stem Cells
9.1.5. Chondrocytes
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Cancer
9.2.2. Neurodegenerative Diseases
9.2.3. Wound Healing
9.2.4. Orthopedic
9.2.5. Cardiovascular Diseases
9.2.6. Autoimmune Diseases
9.2.7. Others
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals and Clinics
9.3.2. Academic and Research Institutes
9.3.3. Others
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. United States
9.4.2. Canada
9.5. North America Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027
9.6. North America Autologous Cell Therapy Market Dynamics Trends
10. Europe Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Bone Marrow
10.1.2. Epidermis
10.1.3. Mesenchymal Stem Cells
10.1.4. Hematopoietic Stem Cells
10.1.5. Chondrocytes
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Cancer
10.2.2. Neurodegenerative Diseases
10.2.3. Wound Healing
10.2.4. Orthopedic
10.2.5. Cardiovascular Diseases
10.2.6. Autoimmune Diseases
10.2.7. Others
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals and Clinics
10.3.2. Academic and Research Institutes
10.3.3. Others
10.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. UK
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027
10.6. Europe Autologous Cell Therapy Market Dynamics Trends
11. Asia Pacific Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Bone Marrow
11.1.2. Epidermis
11.1.3. Mesenchymal Stem Cells
11.1.4. Hematopoietic Stem Cells
11.1.5. Chondrocytes
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Cancer
11.2.2. Neurodegenerative Diseases
11.2.3. Wound Healing
11.2.4. Orthopedic
11.2.5. Cardiovascular Diseases
11.2.6. Autoimmune Diseases
11.2.7. Others
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals and Clinics
11.3.2. Academic and Research Institutes
11.3.3. Others
11.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. ANZ
11.4.4. Japan
11.4.5. Rest of APAC
11.5. Asia Pacific Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027
11.6. Asia Pacific Autologous Cell Therapy Market Dynamics Trends
12. MEA Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Bone Marrow
12.1.2. Epidermis
12.1.3. Mesenchymal Stem Cells
12.1.4. Hematopoietic Stem Cells
12.1.5. Chondrocytes
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Cancer
12.2.2. Neurodegenerative Diseases
12.2.3. Wound Healing
12.2.4. Orthopedic
12.2.5. Cardiovascular Diseases
12.2.6. Autoimmune Diseases
12.2.7. Others
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals and Clinics
12.3.2. Academic and Research Institutes
12.3.3. Others
12.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
12.5. MEA Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027
12.6. MEA Autologous Cell Therapy Market Dynamics Trends
13. Latin America Autologous Cell Therapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Bone Marrow
13.1.2. Epidermis
13.1.3. Mesenchymal Stem Cells
13.1.4. Hematopoietic Stem Cells
13.1.5. Chondrocytes
13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Cancer
13.2.2. Neurodegenerative Diseases
13.2.3. Wound Healing
13.2.4. Orthopedic
13.2.5. Cardiovascular Diseases
13.2.6. Autoimmune Diseases
13.2.7. Others
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals and Clinics
13.3.2. Academic and Research Institutes
13.3.3. Others
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Rest of LA
13.5. Latin America Autologous Cell Therapy Market - Opportunity Analysis Index, By Source, Application, End User, 2016-2027
13.6. Latin America Autologous Cell Therapy Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Brainstorm Cell Therapeutics
14.2.2. Vericel Corporation
14.2.3. Holostem Advanced Therapies
14.2.4. Osiris Therapeutics
14.2.5. Opexa Therapeutics
14.2.6. BioTime Inc.
14.2.7. Phamicell Co. Inc.
14.2.8. Sangamo Therapeutics
14.2.9. Calimmune, Inc.
14.2.10. Bayer, Inc.
15. Research Methodology
16. Key Assumptions and Acronyms

 

  • Brainstorm Cell Therapeutics (U.S.)
  • Vericel Corporation
  • Holostem Advanced Therapies
  • Osiris Therapeutics
  • Opexa Therapeutics
  • BioTime Inc.
  • Phamicell Co. Inc.
  • Sangamo Therapeutics
  • Calimmune, Inc.
  • Bayer, Inc.

Adjacent Markets